Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 42:1994-1999, doi:10.1016/j.jacc.2003.06.015
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schlame, M.
Right arrow Articles by Blanck, T. J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlame, M.
Right arrow Articles by Blanck, T. J. J.

Phospholipid abnormalities in children with Barth syndrome

Michael Schlame, MD*,*, Richard I. Kelley, MD, PhD{dagger}, Annette Feigenbaum, MB, ChB{ddagger}, Jeffrey A. Towbin, MD§, Paul M. Heerdt, MD, PhD||, Thomas Schieble, MD*, Ronald J. A. Wanders, PhD, Salvatore DiMauro, MD# and Thomas J. J. Blanck, MD, PhD*

* Department of Anesthesiology, New York University School of Medicine, New York, New York, USA
{dagger} Division of Metabolism, Kennedy Krieger Institute, Baltimore, Maryland, USA
{ddagger} Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Canada
§ Department of Pediatrics (Cardiology), Baylor College of Medicine, Houston, Texas, USA
|| Department of Anesthesiology, Weill Medical College of Cornell University, New York, New York, USA
Laboratory of Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, The Netherlands
# Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA



View larger version (27K):

[in a new window]
 
Figure 1 Molecular composition of cardiac phosphatidylcholine (PC) and phosphatidylethanolamine (PE) from controls and Barth syndrome (BTHS) patients with tafazzin (TAZ) mutation. Data are means of four measurements (two left ventricle samples and two right ventricle samples). Asterisks indicate a statistically significant difference between control and BTHS (p < 0.05). Diacylglycerol species are listed in the sequence in which they elute from the chromatography column. 16:0 = palmitic acid; 18:0 = stearic acid; 18:1 = oleic acid; 18:2 = linoleic acid; 20:4 = arachidonic acid; 22:5 = docosapentaenoic acid; 22:6 = docosahexaenoic acid.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement